Xbrane Biopharma releases interim report for the third quarter of 2018
November 16, 2018 02:00 ET | Xbrane Biopharma AB
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Press release2018-11-16   Xbrane...
Xbrane Biopharma publicerar kvartalsrapport för juli - september 2018
November 16, 2018 02:00 ET | Xbrane Biopharma AB
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Pressmeddelande 2018-11-16   Xbrane...
Xbrane Biopharma announces results of in-vivo study showing equivalent tolerability and pharmacokinetic profile of Xlucane compared to Lucentis®
October 04, 2018 02:00 ET | Xbrane Biopharma AB
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Press release2018-10-04 In an in-vivo...
Xbrane Biopharma tillkännager resultat från in-vivo studie som påvisar ekvivalent tolerabilitet och farmakokinetisk profil för Xlucane jämfört med Lucentis®
October 04, 2018 02:00 ET | Xbrane Biopharma AB
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Pressmeddelande2018-10-04 I en...
Xbrane Biopharma announces product portfolio update with a new full strategic focus on biosimilars
September 10, 2018 02:00 ET | Xbrane Biopharma AB
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Press release2018-09-10 The board of...
Xbrane Biopharma uppdaterar kring produktportföljen med ett nytt fullt strategiskt fokus på biosimilarer
September 10, 2018 02:00 ET | Xbrane Biopharma AB
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Pressmeddelande2018-09-10 Styrelsen...
Xbrane Biopharma releases interim report for the second quarter of 2018
August 24, 2018 02:00 ET | Xbrane Biopharma AB
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Press release2018-08-24   Xbrane...
Xbrane Biopharma publicerar kvartalsrapport för april - juni 2018
August 24, 2018 02:00 ET | Xbrane Biopharma AB
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Pressmeddelande2018-08-24 Xbrane...
Xbrane invites to a webinar about the recently entered co-development agreement with STADA
July 16, 2018 06:24 ET | Xbrane Biopharma AB
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Press release2018-07-16 Xbrane...
Xbrane bjuder in till ett webbseminarium om det nyligen ingångna samarbetsavtalet med STADA
July 16, 2018 06:24 ET | Xbrane Biopharma AB
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Pressmeddelande2018-07-16 Xbrane...